<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Purinergic Signal</journal-id>
      <journal-title>Purinergic Signalling</journal-title>
      <issn pub-type="ppub">1573-9538</issn>
      <issn pub-type="epub">1573-9546</issn>
      <publisher>
        <publisher-name>Springer Netherlands</publisher-name>
        <publisher-loc>Dordrecht</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">18368534</article-id>
      <article-id pub-id-type="pmc">2246001</article-id>
      <article-id pub-id-type="publisher-id">9093</article-id>
      <article-id pub-id-type="doi">10.1007/s11302-007-9093-8</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Remyelination after chronic spinal cord injury is associated with proliferation of endogenous adult progenitor cells after systemic administration of guanosine</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Jiang</surname>
            <given-names>Shucui</given-names>
          </name>
          <address>
            <phone>+1-905-5212100</phone>
            <fax>+1-905-5219992</fax>
            <email>jiangs@mcmaster.ca</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ballerini</surname>
            <given-names>Patrizia</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Buccella</surname>
            <given-names>Silvana</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Giuliani</surname>
            <given-names>Patricia</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Jiang</surname>
            <given-names>Cai</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Huang</surname>
            <given-names>Xinjie</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rathbone</surname>
            <given-names>Michel P.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Department of Surgery (Neurosurgery, Neurobiology), McMaster University, Health Sciences Centre, 4E15, 1200 Main Street West, Hamilton, ON L8N 3Z5 Canada </aff>
        <aff id="Aff2"><label>2</label>Department of Medicine (Neurology, Neuropharmacology), McMaster University, Health Sciences Centre, 4E15, 1200 Main Street West, Hamilton, ON L8N 3Z5 Canada </aff>
        <aff id="Aff3"><label>3</label>Department of Biomedical Sciences, Universita Degli Studi &#x201C;G. D&#x2019;Annunzio&#x201D;, University of Chieti, Nuovo Polo Didattico, Via Dei Vestini, 31, Chieti, 66013 Italy </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>8</day>
        <month>1</month>
        <year>2008</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>3</month>
        <year>2008</year>
      </pub-date>
      <volume>4</volume>
      <issue>1</issue>
      <fpage>61</fpage>
      <lpage>71</lpage>
      <history>
        <date date-type="received">
          <day>3</day>
          <month>10</month>
          <year>2007</year>
        </date>
        <date date-type="accepted">
          <day>4</day>
          <month>12</month>
          <year>2007</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Springer Science+Business Media B.V. 2007</copyright-statement>
      </permissions>
      <abstract>
        <p>Axonal demyelination is a consistent pathological sequel to chronic brain and spinal cord injuries and disorders that slows or disrupts impulse conduction, causing further functional loss. Since oligodendroglial progenitors are present in the demyelinated areas, failure of remyelination may be due to lack of sufficient proliferation and differentiation of oligodendroglial progenitors. Guanosine stimulates proliferation and differentiation of many types of cells in vitro and exerts neuroprotective effects in the central nervous system (CNS). Five weeks after <italic>chronic</italic> traumatic spinal cord injury (SCI), when there is no ongoing recovery of function, intraperitoneal administration of guanosine daily for 2&#xA0;weeks enhanced functional improvement correlated with the increase in myelination in the injured cord. Emphasis was placed on analysis of oligodendrocytes and NG2-positive (NG2+) cells, an endogenous cell population that may be involved in oligodendrocyte replacement. There was an increase in cell proliferation (measured by bromodeoxyuridine staining) that was attributable to an intensification in progenitor cells (NG2+ cells) associated with an increase in mature oligodendrocytes (determined by Rip+ staining). The numbers of astroglia increased at all test times after administration of guanosine whereas microglia only increased in the later stages (14&#xA0;days). Injected guanosine and its breakdown product guanine accumulated in the spinal cords; there was more guanine than guanosine detected. We conclude that functional improvement and remyelination after systemic administration of guanosine is due to the effect of guanosine/guanine on the proliferation of adult progenitor cells and their maturation into myelin-forming cells. This raises the possibility that administration of guanosine may be useful in the treatment of spinal cord injury or demyelinating diseases such as multiple sclerosis where quiescent oligodendroglial progenitors exist in demyelinated plaques.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>Cell proliferation</kwd>
        <kwd>Functional recovery</kwd>
        <kwd>Guanine</kwd>
        <kwd>Guanosine</kwd>
        <kwd>Immunohistochemistry</kwd>
        <kwd>Myelination</kwd>
        <kwd>Oligodendrocyte</kwd>
        <kwd>Precursors</kwd>
        <kwd>Spinal cord</kwd>
      </kwd-group>
      <custom-meta-wrap>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Springer Science+Business Media B.V. 2008</meta-value>
        </custom-meta>
      </custom-meta-wrap>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Introduction</title>
      <p>Demyelination contributes to functional deficits in central nervous system (CNS) disorders [<xref ref-type="bibr" rid="CR1">1</xref>&#x2013;<xref ref-type="bibr" rid="CR3">3</xref>]. Traumatic spinal cord injury (SCI) induces local inflammation and demyelination in the white matter around the lesion resulting in disrupted axonal conduction [<xref ref-type="bibr" rid="CR4">4</xref>&#x2013;<xref ref-type="bibr" rid="CR7">7</xref>]. Remyelination is critical for recovery, but does not occur spontaneously [<xref ref-type="bibr" rid="CR8">8</xref>&#x2013;<xref ref-type="bibr" rid="CR11">11</xref>]. Spinal cords contain endogenous progenitors that can proliferate and differentiate into mature oligodendroglia and remyelinate axons under certain circumstances [<xref ref-type="bibr" rid="CR12">12</xref>&#x2013;<xref ref-type="bibr" rid="CR14">14</xref>]. After acute SCI in rats, oligodendrocyte precursors proliferate in the first 2&#xA0;weeks but are &#x201C;silent&#x201D; thereafter [<xref ref-type="bibr" rid="CR15">15</xref>], possibly because the oligodendroglial precursors cannot differentiate into mature oligodendroglia capable of remyelinating axons. Enhancement of proliferation of oligodendrocytes or progenitors may lead to repair and restoration of function after SCI.</p>
      <p>Neurotrophic factors restore physiological function by promoting oligodendrocyte proliferation and axonal sprouting [<xref ref-type="bibr" rid="CR16">16</xref>&#x2013;<xref ref-type="bibr" rid="CR19">19</xref>], regulating the proliferation of oligodendrocyte progenitors [<xref ref-type="bibr" rid="CR3">3</xref>] and modulating the differentiation [<xref ref-type="bibr" rid="CR20">20</xref>&#x2013;<xref ref-type="bibr" rid="CR22">22</xref>] and the maturation of oligodendrocyte precursors into myelin-forming cells [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>].</p>
      <p>Guanosine has trophic effects on many cell types [<xref ref-type="bibr" rid="CR25">25</xref>&#x2013;<xref ref-type="bibr" rid="CR28">28</xref>], and we have some evidence that guanine acts similarly. For example, it stimulates proliferation of a variety of cells in culture [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR28">28</xref>] and promotes synthesis and release of several potentially neuroprotective trophic factors from a variety of cells, including neuron growth factor (NGF) from astrocytes as well as basic fibroblast growth factor (bFGF) and transforming growth factor beta (TGF beta) [<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. Extracellular guanosine itself also enhances outgrowth of nerve processes from PC12 cells and from primary cultures of embryonic rat brain neurons [<xref ref-type="bibr" rid="CR25">25</xref>]. As well, it acts synergistically with NGF to promote outgrowth of neurites [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>].</p>
      <p>Our preliminary data [<xref ref-type="bibr" rid="CR31">31</xref>] showed that 35&#xA0;days after moderate traumatic injury of the spinal cord of rats, when the initial spontaneous incomplete recovery of function had plateaued, systemic administration of guanosine (intraperitoneally 8&#xA0;mg/kg body weight) for 7&#xA0;days enhanced locomotor functional recovery that continued to improve throughout the 7-day duration of the treatment and correlated with the increase in myelination. In the present study, we treated rats for up to 14&#xA0;days to determine whether guanosine-induced functional improvement was due to triggering the endogenous adult progenitors. Meanwhile, we also examined the uptake and tissue distribution of systemically administered guanosine.</p>
    </sec>
    <sec id="Sec2" sec-type="materials|methods">
      <title>Materials and methods</title>
      <p>All experiments were performed in compliance with the requirements of the Animals for Research Act of Ontario, Canada and the Guidelines of the Canadian Council on Animal Care, and had been approved by the Animal Research Ethics Board of McMaster University.</p>
      <p><bold>Spinal cord injury</bold> Adult female Wistar rats (280&#x2013;300&#xA0;g weight, Charles River) were anaesthetized with isoflurane (3&#x2013;5%): O<sub>2</sub> (1&#xA0;l/min). Buprenorphine (0.03&#xA0;mg/kg body weight, subcutaneously) was administered prior to surgery for pain relief. Moderate spinal cord injury was induced by crushing exposed cords with modified coverslip forceps [<xref ref-type="bibr" rid="CR31">31</xref>&#x2013;<xref ref-type="bibr" rid="CR33">33</xref>]. The forceps were closed slowly over 2&#xA0;s and the compression sustained for 15&#xA0;s. The muscles and fat pad over the lesion were sutured and the skin was closed with stainless steel clips. Post-operatively, the rats were kept quiet and warm [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>].</p>
      <p><bold>Behavioural assessment and drug administration</bold> Rats were handled daily for 2&#xA0;weeks pre-operatively to acclimatize them to the experimental procedures and behavioural test. After the spinal injury, locomotor recovery was assessed weekly for 35&#xA0;days in an open field walking task (OFWT) before treatment. Cagemates (two animals) were placed in the centre of the open field, formed by a child&#x2019;s circular plastic swimming pool (1.3&#xA0;m in diameter). They were observed for 5-min periods and scored for general locomotor ability using the Basso-Beattie-Bresnahan (BBB) locomotor rating scale [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>]. Rats were rated on a scale of 0 to 21, with 0 being no function and 21 being normal. If the animal stopped moving for a minute, it was placed again in the centre of the open field; otherwise it was left alone for the duration of the 5-min test period.On day 35 following the injury, rats were randomly assigned to three groups. One group of rats was used for baseline behavioural and histological analysis. The other rats received either daily intraperitoneal (i.p.) injections of 8&#xA0;mg/kg guanosine or the same volume of saline containing 0.001&#xA0;N NaOH [<xref ref-type="bibr" rid="CR31">31</xref>] for 2&#xA0;weeks. The open field walking testing was performed once a day from days 35 to 48 post-surgery (0 to 14&#xA0;days post-treatment). Groups of 9&#x2013;12 rats were killed by perfusion/fixation for immunohistochemical analysis at 1, 3, 7 or 14&#xA0;days after treatment.</p>
      <p><bold>BrdU administration</bold> Bromodeoxyuridine (BrdU) was used to label proliferating cells after treatment. BrdU (50&#xA0;mg/kg in sterile saline; Sigma, B-5002) was injected intraperitoneally daily for 1, 3, 7 or 14 consecutive days, beginning the day treatment was initiated, thereby reflecting cell proliferation over the entire treatment period.</p>
      <p><bold>Tissue processing and immunohistochemistry</bold> On post-operative days 35, 36, 38, 42 or 49 (representing baseline, 1, 3, 7 or 14&#xA0;days treatment), rats were deeply anaesthetized with sodium pentobarbital (50&#x2013;60&#xA0;mg/kg body weight, i.p.) immediately following the final locomotor testing and perfused transcardially with 100&#xA0;ml 0.1&#xA0;M phosphate-buffered saline (PBS) containing 0.1% heparin, followed by 300&#x2013;500&#xA0;ml of 4% paraformaldehyde (PFA). T9 to L1 segments of the spinal cords were removed and incubated in the same fixative for 2&#xA0;h at room temperature and then cryoprotected in 30% sucrose PBS solution. A segment of each cord, extending from 5&#xA0;mm rostral to 5&#xA0;mm caudal to the lesion site was embedded in medium (Tissue-Tek&#xAE; O.C.T. compound, Sakura Finetek USA, Inc., Torrance, CA, USA). Serial transverse sections were cut at 15- to 20-&#x3BC;m intervals on a cryostat and mounted onto slides (ColorFrost/Plus; Fisher, Pittsburgh, PA, USA). Every fifth section was stained with the lipophilic dye Luxol fast blue to stain myelin [<xref ref-type="bibr" rid="CR38">38</xref>]. Adjacent sections were stained immunohistochemically with the various antibodies described below.For BrdU immunohistochemistry, 6% hydrogen peroxide was used to reduce endogenous peroxidase activity, followed by three 10-min PBS rinses and incubation in 1&#xA0;N HCl at 37&#xB0;C for 30&#xA0;min. After rinsing, a blocking solution [5% bovine serum albumin (BSA) in 0.1% Triton-100] was applied for 1&#xA0;h; sections were subsequently incubated in rat anti-BrdU (1:200 in 1% BSA in 0.1% Triton-100; Serotec, Raleigh, NC, USA) at 4&#xB0;C overnight in a humid chamber. Sections were then rinsed and incubated with biotinylated horse anti-rat IgG secondary antibodies. Sections were then incubated with <italic>Elite</italic> ABC (Vector Laboratories, Burlingame, CA, USA) for 1&#xA0;h, followed by 3,3&#x2032;-diaminobenzidine (DAB) substrate kit for peroxidase (Vector Laboratories, Burlingame, CA, USA) for 5&#x2013;10&#xA0;min. Sections were dehydrated, coverslipped and examined under a microscope.To determine the fate of newly born cells after SCI, double-fluorescent immunolabelling was performed, combining BrdU with one of the cell-specific phenotypic markers listed below. For double immunofluorescence, sections were pretreated with HCl as described above and incubated with BrdU antibody mixed with one of the following antibodies in PBS at 4&#xB0;C overnight in a humid chamber: rabbit anti-MBP (myelin basic protein) polyclonal antibodies (1:50; Chemicon Int., Temecula, CA, USA), rabbit anti-NG2 polyclonal antibodies (chondroitin sulfate proteoglycan for oligodendroglial progenitors; 1:200; Chemicon Int. Temecula, CA, USA), mouse anti-Rip monoclonal antibodies (mature oligodendrocyte-specific marker: Reactive Immunology Protein; 1:200; Chemicon Int., Temecula, CA, USA; [<xref ref-type="bibr" rid="CR39">39</xref>]), rabbit anti-glial fibrillary acidic protein (GFAP) polyclonal antibodies (1:600; Zymed&#xAE; Lab-SA System Kit, San Francisco, CA, USA) and mouse anti-microglial-specific marker OX-42 monoclonal antibodies (1:200; CD11b, Research Diagnostics Inc., Flanders, NJ, USA). For Rip and OX-42 monoclonal antibodies single staining, sections were developed with fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse IgG. For BrdU and polyclonal antibodies (NG2 or MBP or GFAP) double immunolabelling, sections were developed using a mixture of FITC-conjugated goat anti-rat IgG and rhodamine-conjugated goat anti-rabbit IgG in 1% normal goat serum and 0.25% Triton X-100; 1:200 (Invitrogen, Carlsbad, CA, USA) for 2&#xA0;h. To examine the contribution of Schwann cells from the peripheral nervous system (PNS) in the remyelination process, sections were immunolabelled with specific markers for Schwann cell myelin P0 (a rabbit polyclonal anti-P0 antibody was kindly donated by Prof. Marie T. Filbin, Department of Biology, CUNY, NY, USA; 1:200) and secondary antibody using rhodamine-conjugated goat anti-rabbit IgG. For detection of apoptotic cells, a terminal deoxynucleotidyltransferase (TdT)-mediated dUTP nick end labelling (TUNEL) stain was performed using the &#x2018;In situ Cell Death Detection Kit, Fluorescein&#x2019; (Roche Molecular Biochemicals, Mannheim, Germany), according to the manufacturer&#x2019;s instructions.</p>
      <p><bold>Quantification</bold> To quantify the amount of myelin present at the injury site before and after treatment, the Luxol fast blue-stained section from each cord (<italic>n</italic>&#x2009;=&#x2009;7&#x2013;10 for each group) that contained the greatest lesion area was selected together with the adjacent two caudal and two rostral Luxol blue-stained sections. Luxol fast blue staining was also done on cords of five additional unoperated normal animals for comparative purposes. Digital photographs were taken of the sections. The total area of each section and the area of the fast blue-stained portion were measured using a computerised Bioquant BQ-TCW98 image analysis program by an investigator who was blind to group assignment.For quantification of cell proliferation, five to seven sections taken from the penumbra of the lesion and spaced about 100&#xA0;&#x3BC;m apart were analysed for each animal (<italic>n</italic>&#x2009;=&#x2009;7&#x2013;9 animals per group). Cellular proliferation was determined by counting the total number of BrdU+ nuclei in spinal cord cross sections. Low power sections were digitized and manually outlined using an image analysis system. Any cavities present in the sections were excluded from analysis. Positively labelled nuclei were counted automatically. The threshold was set such that only positively labelled profiles of the appropriate size were counted. Data are expressed as cells per section.The total number of NG2+ progenitor cells and the number of those that proliferated (double-labelled for NG2 and BrdU: NG2+/BrdU+) was determined by manual counting. Cell counting was done conservatively, and a positive profile was counted as a cell only when clearly defined borders could be detected completely around and adjacent to the entire nucleus. Data are expressed as the number of immunostained cells per section.Mature oligodendrocytes in injured cords were identified with Rip, a specific marker for mature oligodendrocytes that recognises an unknown epitope [<xref ref-type="bibr" rid="CR39">39</xref>] and has been used successfully in the CNS to label both oligodendrocyte processes and myelin sheaths. The number of mature oligodendrocyte (Rip+ cells) in the tissue sections was determined by manual counting.</p>
      <p><bold>Evaluation of exogenous guanosine distribution</bold> A guanosine solution (8&#xA0;mg/kg) was administered intraperitoneally to rats with spinal cord injury induced 5&#xA0;weeks previously. Samples of spinal cord were taken from the site of the lesion and immediately above or below the lesion just before the intraperitoneal injection of guanosine and at 7.5, 30 and 60&#xA0;min after the guanosine injection. There were between three and six animals at each time point. Samples of spinal cord were placed in 0.5&#xA0;ml of cold 0.4&#xA0;M perchloric acid solution and immediately homogenized. Samples were then centrifuged (4&#xB0;C, 10,000&#xA0;<italic>g</italic>, 10&#xA0;min) to remove proteins precipitated by perchloric acid and the supernates containing the soluble molecules were neutralized with KOH solution and centrifuged (4&#xB0;C, 10,000&#xA0;<italic>g</italic>, 5&#xA0;min). Samples were filtered with 0.2-&#x3BC;m filters (Millipore, Billerica, MA, USA) and stored at &#x2212;70&#xB0;C before high-performance liquid chromatography (HPLC) [<xref ref-type="bibr" rid="CR40">40</xref>] or capillary electrophoresis (CE) analysis.</p>
      <p><bold>Tissue concentrations of guanosine and guanine</bold> To evaluate the concentration of guanosine and its principal degradation product, guanine, in spinal cords before and after the intraperitoneal injection of guanosine, either HPLC or CE was used. There was no significant difference in the values obtained by these two methods so the data represent the mean of values obtained by both analyses. HPLC analysis was carried out using an Agilent 1100 series HPLC (Agilent Technologies, Waldbronn, Germany) and an ion-pair technique. Separation was carried out with a reverse-phase analytical column (LiChroCART 125-4 LiChrospher 100 RP-18 5&#xA0;&#x3BC;m, Merck, Darmstadt, Germany) and the flow rate was 1.5&#xA0;ml/min. A 15-min linear gradient was applied from 100% buffer A (60&#xA0;mM KH<sub>2</sub>PO<sub>4</sub> and 5&#xA0;mM tetrabutylammonium phosphate, pH 6) to 100% buffer B (30% methanol plus 70% buffer A). CE separations were carried out using an HP<sup>3D</sup>CE capillary electrophoresis system (Agilent Technologies, Waldbronn, Germany) equipped with a diode array detection system. Analysis was performed using a 80.5&#xA0;cm &#xD7; 50&#xA0;&#x3BC;m ID &#xD7; 375&#xA0;&#x3BC;m OD uncoated fused silica capillary from Agilent Technologies (Waldbronn, Germany) with an effective length of 72&#xA0;cm to the detector window. The capillary temperature was kept constant at 37&#xB0;C and the running buffer was 10&#xA0;mM borate, pH 9.3. The samples were injected by pressure (50&#xA0;mb for 40&#xA0;s) and the separation was conducted at 22&#xA0;kV. Detection took place at 254&#xA0;nm and purines were identified by their migration times and UV spectra using the diode array detector (Agilent Technologies, Waldbronn, Germany).</p>
      <p><bold>Statistical analysis</bold> Data are expressed as mean&#x2009;&#xB1;&#x2009;SEM. Behavioural scores were analysed by the Kruskal-Wallis non-parametric analysis of variance (ANOVA). Post hoc comparisons were made using the Dunnett&#x2019;s test. Correlation between behavioural and histological outcomes was analysed using regression analysis. Significance was set at <italic>p</italic>&#x2009;&lt;&#x2009;0.05.</p>
    </sec>
    <sec id="Sec3">
      <title>Results and discussion</title>
      <p>After SCI, motor function in the legs partially recovered over 3&#x2013;4&#xA0;weeks, after which there was no further improvement (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>a). Daily guanosine for 14&#xA0;days (8&#xA0;mg/kg intraperitoneally beginning 35&#xA0;days after injury) produced improvement in locomotor performance over the next 2&#xA0;weeks; control rats showed no improvement (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>b). This treatment regimen was associated with significantly increased amounts of myelin in the penumbra of the cord lesions shown by Luxol fast blue staining (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>c&#x2013;e). The extent of Luxol fast blue staining in the injured cords correlated with each animal&#x2019;s open field walking scores (<italic>r</italic>&#x2009;=&#x2009;0.72; <italic>p</italic>&#x2009;&lt;&#x2009;0.05; Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>f), indicating that guanosine-induced functional recovery may be related to the increase in myelin. Immunostaining for CNS myelin basic protein (MBP; Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>g,h) and a specific marker for Schwann cell myelin, P0 (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>i,j) showed that Schwann cells from the peripheral nervous system did not enter spinal cord and, therefore, did not contribute to the remyelination.
<fig id="Fig1"><label>Fig.&#xA0;1</label><caption><p>Systemic treatment with guanosine improves locomotor function and correlates with increased myelination in rats with stable chronic spinal cord injury. <bold>a</bold> After spinal cord crush, locomotor function was assessed in an open field walking task (OFWT) and scored using a standard scale (&#x201C;<xref rid="Sec2" ref-type="sec">Materials and methods</xref>&#x201D;). No further improvement in locomotor performance occurred after 28&#xA0;days. <bold>b</bold> On days 35&#x2013;48 after injury (days 1 to 14 of treatment in the figure; the first test done immediately prior to the first treatment), animals were randomly divided into two groups. One group received guanosine (&#x25B4;), the other group received vehicle (&#x2666;). The locomotor function in the control group did not change significantly throughout the 14&#xA0;days of vehicle administration. In contrast, rats that received guanosine showed a marked improvement in locomotor behaviour, which was significantly (<italic>p</italic>&#x2009;&lt;&#x2009;0.05) better than vehicle-treated control animals from the 5th day of treatment onward. <bold>c</bold>, <bold>d</bold> Luxol fast blue staining of cross sections of spinal cords from guanosine- (<bold>d</bold>) and vehicle- (<bold>c</bold>) treated animals at the lesion site 48&#xA0;days after the initial lesion (after 14&#xA0;days treatment) shows increased Luxol fast blue-stained material in <bold>d</bold> compared to the vehicle-treated control group in <bold>c</bold>. <italic>DC</italic> dorsal column at the lesion. Scale bar&#x2009;=&#x2009;50&#xA0;&#x3BC;m. <bold>e</bold> The total area of each section and of the Luxol fast blue-stained portion were measured following the protocol in &#x201C;<xref rid="Sec2" ref-type="sec">Materials and methods</xref>&#x201D;. The quantitative results show that the cords from guanosine-treated animals had significantly greater myelinated area (*<italic>p</italic>&#x2009;&lt;&#x2009;0.05), as estimated from the Luxol fast blue staining, than cords from vehicle-treated control animals, which in turn had significantly less myelinated area (**<italic>p</italic>&#x2009;&lt;&#x2009;0.001) than unoperated animals. <bold>f</bold> Correlation between behavioural and histological outcomes was analysed using regression analysis. The data show that the Luxol fast blue-stained area in the injured cords from animals treated with guanosine correlated with their behavioural recovery in open field walking scores, correlation coefficient of 0.72, indicating that the recovery of function may be related to the increase in myelin. Myelin immunofluorescent staining of cross sections of spinal cords from vehicle- (<bold>g</bold>) and guanosine- (<bold>h</bold>) treated animals at the lesion site 14&#xA0;days after treatment shows that guanosine-treated cords (<bold>h</bold>) contained more myelin basic protein (MBP)-positive profiles from central nervous system at the injured site compared to the vehicle-treated control group (<bold>g</bold>). <italic>IS</italic> injured site. Whereas, in <bold>i</bold> (vehicle-treated cord) and <bold>j</bold> (guanosine-treated cord) immunolabelling with specific markers for Schwann cell myelin P0 indicated that Schwann cells from the peripheral nervous system did not contribute to guanosine-induced remyelination. Scale bar&#x2009;=&#x2009;50&#xA0;&#x3BC;m for all</p></caption><graphic position="anchor" xlink:href="11302_2007_9093_Fig1a-f_HTML" id="MO1"/></fig></p>
      <p>To determine whether existing cells elaborated the myelin or whether it was a product of other cells that proliferated and subsequently elaborated myelin, the number of proliferating cells was determined by counting all BrdU+ nuclei in cross sections of the lesion penumbra at different times after treatment. In the first 3&#xA0;days after treatment, cell proliferation at the injury site in both guanosine-treated and control animals was not different from baseline (immediately before treatment; Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>c), although at 3&#xA0;days there was a trend toward more BrdU+ cells in guanosine-treated animals than controls (112&#x2009;&#xB1;&#x2009;25 vs 79&#x2009;&#xB1;&#x2009;16). At 7 and 14&#xA0;days after guanosine treatment, the number of BrdU+ cells increased significantly; there were 382&#x2009;&#xB1;&#x2009;42 BrdU+ cells per section at 7&#xA0;days and 477&#x2009;&#xB1;&#x2009;49 at 14&#xA0;days compared with only 88&#x2009;&#xB1;&#x2009;20 at 7&#xA0;days and 95&#x2009;&#xB1;&#x2009;22 at 14&#xA0;days in controls (<italic>p</italic>&#x2009;&lt;&#x2009;0.05; Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>a&#x2013;c). There were few dividing cells beyond the lesion margins.
<fig id="Fig2"><label>Fig.&#xA0;2</label><caption><p>Quantitative assessment of immunostaining shows that systemic treatment with guanosine stimulates endogenous oligodendroglial progenitors (NG2+ cells) to proliferate and mature in rats with stable chronic spinal cord injury. <bold>a</bold>, <bold>b</bold> Bromodeoxyuridine (BrdU) was used to label proliferating cells after treatment. BrdU immunostaining in cross sections from vehicle- (<bold>a</bold>) and guanosine- (<bold>b</bold>) treated animals at the lesion 14&#xA0;days after treatment shows increased BrdU+ nuclei in <bold>b</bold> compared to the vehicle-treated control group in <bold>a</bold>. Scale bar&#x2009;=&#x2009;50&#xA0;&#x3BC;m. <bold>c</bold> Quantitative analysis shows that 7 or 14&#xA0;days after guanosine treatment there was a significant increase in the number of BrdU+ cells compared with vehicle-treated controls. <bold>d</bold>, <bold>e</bold> Demonstrate examples of double-fluorescent immunostaining using antibodies against BrdU (<italic>in green</italic>) and a marker (NG2) for oligodendroglial progenitors (<italic>in red</italic>) in cross sections from vehicle- (<bold>d</bold>) and guanosine- (<bold>e</bold>) treated animals at the lesion 14&#xA0;days after treatment. Scale bar&#x2009;=&#x2009;50&#xA0;&#x3BC;m. <bold>f</bold>&#x2013;<bold>h</bold> Show quantification of proliferating progenitors (NG2+/BrdU+ double-labelled cells; <bold>f</bold>) and total number of NG2 cells (<bold>g</bold>). Data indicate that after 7 or 14&#xA0;days administration guanosine significantly stimulates proliferation of oligodendroglial progenitors (<bold>f</bold>, <bold>g</bold>). Concurrently, guanosine also significantly increases the number of mature oligodendroglia shown in <bold>i</bold> and <bold>j</bold> compared to vehicle-treated controls (<bold>h</bold>, <bold>j</bold>) using fluorescent immunostaining with a specific marker (Rip) to label the mature oligodendroglia. Scale bar&#x2009;=&#x2009;50&#xA0;&#x3BC;m</p></caption><graphic position="anchor" xlink:href="11302_2007_9093_Fig2a-g_HTML" id="MO2"/></fig></p>
      <p>Oligodendrocytes that survive the demyelinating insult are not thought to be able to contribute to remyelination [<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR42">42</xref>]. Instead, endogenous oligodendrocyte progenitor cells local to the lesion are believed to be the source of new myelinating cells [<xref ref-type="bibr" rid="CR43">43</xref>]. Previous studies have illustrated that NG2+ cells are the major cycling cell within the resting adult CNS [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR44">44</xref>] and express many characteristics of oligodendroglial lineage cells, not least their ability to differentiate into oligodendrocytes when isolated into culture. Their role in demyelination and remyelination has been extensively studied and there is evidence that they are the cells responsible for myelin repair [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR45">45</xref>&#x2013;<xref ref-type="bibr" rid="CR48">48</xref>]. To determine whether the proliferating cells were related to NG2+ oligodendroglial progenitor cells, we counted the total number of NG2+ progenitor cells and the number that had proliferated (NG2+/BrdU+) from 2&#xA0;mm rostral to 2&#xA0;mm caudal to the lesion site (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>d,e). There was minimal turnover in the NG2+ cells in the spinal cord during the first 3&#xA0;days in both guanosine-treated and control animals (13&#x2009;&#xB1;&#x2009;5 in the guanosine group vs 9&#x2009;&#xB1;&#x2009;4 cells per section in controls; Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>f). By 7&#xA0;days, guanosine significantly stimulated progenitor proliferation (85&#x2009;&#xB1;&#x2009;18 vs 13&#x2009;&#xB1;&#x2009;4 NG2+/BrdU+ cells/section; Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>f); these cells were observed throughout the penumbra with the majority localised in the dorsal columns. Enhanced proliferation of the NG2+ progenitors after guanosine persisted, and by 14&#xA0;days, double-labelled progenitors in the guanosine-treated group were eightfold more than in controls (108&#x2009;&#xB1;&#x2009;12 vs 13&#x2009;&#xB1;&#x2009;5 NG2+/BrdU+ cells/section; Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>f).</p>
      <p>The total number of NG2+ cells was also determined. During the first 3&#xA0;days, there was no significant difference in the numbers of NG2+ cells in cords at baseline after vehicle treatment or guanosine treatment (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>g). By 7&#xA0;days, guanosine treatment increased the total NG2+ cells from 96&#x2009;&#xB1;&#x2009;22 cells/section at baseline to 266&#x2009;&#xB1;&#x2009;38 cells/section&#x2014;more than 2 times higher than in the control group (110&#x2009;&#xB1;&#x2009;24 /section; Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>g). By 14&#xA0;days, the numbers of double-labelled progenitors in the cords of guanosine-treated animals were threefold higher than controls (347&#x2009;&#xB1;&#x2009;36 NG2+ cells/section for guanosine-treated animals; 115&#x2009;&#xB1;&#x2009;24 cells/section for controls; Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>g).</p>
      <p>Mature oligodendrocytes were identified with Rip+ staining (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>h,i). Guanosine had no effect on mature oligodendroglia 3&#xA0;days after treatment; at 7 and 14&#xA0;days, there was a significant increase in Rip+ cells in the penumbra of the cords of animals that had received guanosine compared to controls (7&#xA0;days: 468&#x2009;&#xB1;&#x2009;40 vs 205&#x2009;&#xB1;&#x2009;25; and at 14&#xA0;days: 492&#x2009;&#xB1;&#x2009;43 vs 219&#x2009;&#xB1;&#x2009;23 per section, <italic>p</italic>&#x2009;&lt;&#x2009;0.01; Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>j).</p>
      <p>Guanosine treatment stimulated astrocyte proliferation in the penumbra as early as 3&#xA0;days and throughout the 14&#xA0;days of treatment (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>a,b) and was detected by antibodies to glial fibrillary acidic protein (GFAP). Astrocytes may stimulate oligodendroglial progenitor proliferation or induce their migration [<xref ref-type="bibr" rid="CR49">49</xref>]. Guanosine did not alter the numbers of OX-42+ microglia/macrophages until 14&#xA0;days after treatment. At day 14, guanosine significantly increased OX-42+ cells compared to vehicle treatment (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>c&#x2013;e; <italic>p</italic>&#x2009;&lt;&#x2009;0.05).
<fig id="Fig3"><label>Fig.&#xA0;3</label><caption><p>Cross sections of the cords at the injury site staining with GFAP and OX-42 from guanosine-treated and vehicle-treated rats 14&#xA0;days after treatment following chronic spinal cord injury. <bold>a</bold>, <bold>b</bold> Demonstrate examples of GFAP-positive astrocytes (<italic>in red</italic>) in cross sections from vehicle- (<bold>a</bold>) and guanosine- (<bold>b</bold>) treated animals at the injury site 14&#xA0;days after treatment. <bold>c</bold>, <bold>d</bold> Show OX-42-immunofluorescent staining of cross sections of spinal cords from vehicle- (<bold>c</bold>) and guanosine- (<bold>d</bold>) treated animals at the lesion site 14&#xA0;days after treatment. Quantification showed more OX-42-immunolabelled cells in cords of guanosine-treated rats (<bold>d</bold>, <bold>e</bold>) compared to cords of vehicle-treated rats (<bold>c</bold>, <bold>e</bold>; <italic>p</italic>&#x2009;&lt;&#x2009;0.05). Scale bar&#x2009;=&#x2009;50&#xA0;&#x3BC;m for all</p></caption><graphic position="anchor" xlink:href="11302_2007_9093_Fig3_HTML" id="MO3"/></fig></p>
      <p>Guanosine inhibits apoptosis due to a number of stimuli [<xref ref-type="bibr" rid="CR50">50</xref>&#x2013;<xref ref-type="bibr" rid="CR52">52</xref>]. After stroke and spinal cord injury, intrinsic stem cells and progenitors proliferate and differentiate but many die through apoptosis [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR53">53</xref>&#x2013;<xref ref-type="bibr" rid="CR55">55</xref>]. In these experiments, guanosine did not prevent cell death (measured by TUNEL) (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>), indicating that the protective effects of guanosine do not result from a reduction in precursor cell apoptosis.
<fig id="Fig4"><label>Fig.&#xA0;4</label><caption><p>Guanosine treatment did not affect apoptosis in the cords with chronic, stable spinal cord injury. For detection of apoptotic cells, a terminal deoxynucleotidyltransferase (TdT)-mediated dUTP nick end labelling (TUNEL) stain was performed using the &#x2018;In situ Cell Death Detection Kit, Fluorescein&#x2019;. No obvious difference in number of TUNEL-positive cells was observed between vehicle- (<bold>a</bold>) or guanosine- (<bold>b</bold>) treated spinal cord sections. Scale bar&#x2009;=&#x2009;50&#xA0;&#x3BC;m for all</p></caption><graphic position="anchor" xlink:href="11302_2007_9093_Fig4_HTML" id="MO4"/></fig></p>
      <p>Before the intraperitoneal injection of guanosine, there were detectable amounts of guanosine and its metabolic product guanine in the spinal cords of injured rats (time 0, Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>a,b). There were no significant differences in guanosine or guanine in the samples of the spinal cords above, at or below the lesion. After guanosine injection, the amount of both guanosine and guanine increased, reaching a maximum by 30&#xA0;min; the amounts of guanosine and guanine were about twofold and fivefold higher than those detected before the injection (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>a,b). As with the basal levels (time 0), there was no difference in the amounts of guanosine above, at or below the lesion. Interestingly, guanine levels were always higher than those of guanosine at each of the times tested after injection (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>a,b).
<fig id="Fig5"><label>Fig.&#xA0;5</label><caption><p>Guanosine (<bold>a</bold>) and guanine (<bold>b</bold>) in spinal cord samples of rats with chronic spinal cord injury before and after intraperitoneal injection of guanosine. Guanosine (8&#xA0;mg/kg) was administered intraperitoneally to rats 5&#xA0;weeks after the spinal cord injury. Before or at the indicated time points after the injection, samples of spinal cord from 3&#x2013;6 animals were taken from the site of the lesion and immediately above and below the lesion. The tissue content of guanosine and its metabolic product guanine was measured by HPLC and CE analysis. Data are the mean&#x2009;&#xB1;&#x2009;SEM</p></caption><graphic position="anchor" xlink:href="11302_2007_9093_Fig5_HTML" id="MO5"/></fig></p>
      <p>New oligodendrocytes in injured spinal cords come from a population of endogenous progenitor cells present in the CNS that can differentiate into mature cells capable of myelinating axons [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR56">56</xref>]. The data from the present study showed that the increase in the number of NG2+ cells is associated with an increase in Rip+ cells. Our data indicated that guanosine treatment induced an increase of mature oligodendroglia (Rip+ cells), likely due to proliferation and differentiation of their progenitor (NG2+) cells. Therefore, one would expect that Rip+ cells increase after NG2+ cells. However, this was not observed. But guanosine may well stimulate the proliferation of oligodendroglial progenitor cells at several stages of development. This would account for the observed results. Additionally, we cannot exclude that other possible mechanisms are involved in the process; for example, mature oligodendroglia could migrate from the adjacent normal tissue to the injury site soon after guanosine treatment.</p>
      <p>Whether the effects on remyelination are due to guanosine, guanine or both is not clear. However, since a putative receptor for guanosine has been identified in the CNS, and since PNP (purine nucleoside phosphorylase) in CNS permits the interconversion of guanine and guanosine enabling guanine to act as a reservoir for guanosine, it is possible that guanosine may be responsible for causing the proliferation of the endogenous progenitor cells and the subsequent remyelination process, although this is by no means certain. But, since guanine itself is difficult to administer because of its poor solubility, administration of guanosine is the most effective delivery mechanism.</p>
      <p>The mechanism by which remyelination is facilitated after chronic, traumatic SCI is unknown. Guanosine has been shown to stimulate the production and/or release of a variety of trophic factors [<xref ref-type="bibr" rid="CR25">25</xref>]; for example bFGF, NGF and NT-3 have been demonstrated to increase the proliferation and survival of oligodendrocyte progenitors [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR57">57</xref>], induce oligodendroglial genesis [<xref ref-type="bibr" rid="CR58">58</xref>&#x2013;<xref ref-type="bibr" rid="CR61">61</xref>], stimulate the proliferation of oligodendrocyte precursors and enhance remyelination after spinal cord traumatic injury [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>] and after toxin-induced demyelination [<xref ref-type="bibr" rid="CR62">62</xref>]. There are no published reports of the effects of guanine in the vivo systems. However, in cultured cells, guanosine stimulates cell division apparently through a pertussis toxin-sensitive process involving MAP kinase [<xref ref-type="bibr" rid="CR63">63</xref>]. Moreover, there is evidence of a G protein-coupled receptor in brain membranes that might be a candidate for a guanosine receptor [<xref ref-type="bibr" rid="CR64">64</xref>]. Further studies will permit us to distinguish amongst these possibilities.</p>
      <p>The present findings are the first to show that systemic treatment with guanosine after chronic SCI induces an improvement in function that is accompanied by the formation of mature oligodendrocytes. This effect of guanosine/guanine may be attributable to direct or indirect stimulation of endogenous oligodendrocyte lineage progenitors in the spinal cord and remyelination of axons at the injury site.</p>
      <p>These findings raise the possibility that the administration of guanosine may be effective in treating spinal cord injuries and in the treatment of demyelinating diseases such as multiple sclerosis where quiescent progenitors exist in demyelinated plaques [<xref ref-type="bibr" rid="CR65">65</xref>&#x2013;<xref ref-type="bibr" rid="CR70">70</xref>].</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgements</title>
      <p>We thank Dr. Raelene Kinlough-Rathbone for her helpful suggestions and critical appraisal of the manuscript, and Drs. Richard Borgens, Andrew Blight, and John Gruner for advice on the spinal crush model. We are grateful to Prof. Marie T. Filbin, Department of Biological Sciences, CUNY, NY, for kindly providing the anti-P0.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bunge</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Bunge</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Ris</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Ultrastructural study of remyelination in an experimental lesion in adult cat spinal cord</article-title>
          <source>J Biophys Biochem Cytol</source>
          <year>1961</year>
          <volume>10</volume>
          <fpage>67</fpage>
          <lpage>94</lpage>
        </citation>
        <citation citation-type="display-unstructured">Bunge MB, Bunge RP, Ris H (1961) Ultrastructural study of remyelination in an experimental lesion in adult cat spinal cord. J Biophys Biochem Cytol 10:67&#x2013;94 <pub-id pub-id-type="pmid">13688845</pub-id></citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bunge</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Puckett</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>Becerra</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Marcillo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Quencer</surname>
              <given-names>RM</given-names>
            </name>
          </person-group>
          <article-title>Observations on the pathology of human spinal cord injury. A review and classification of 22 new cases with details from a case of chronic cord compression with extensive focal demyelination</article-title>
          <source>Adv Neurol</source>
          <year>1993</year>
          <volume>59</volume>
          <fpage>75</fpage>
          <lpage>89</lpage>
        </citation>
        <citation citation-type="display-unstructured">Bunge RP, Puckett WR, Becerra JL, Marcillo A, Quencer RM (1993) Observations on the pathology of human spinal cord injury. A review and classification of 22 new cases with details from a case of chronic cord compression with extensive focal demyelination. Adv Neurol 59:75&#x2013;89 <pub-id pub-id-type="pmid">8420126</pub-id></citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McDonald</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Belegu</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Demyelination and remyelination after spinal cord injury</article-title>
          <source>J Neurotrauma</source>
          <year>2006</year>
          <volume>23</volume>
          <fpage>345</fpage>
          <lpage>359</lpage>
          <pub-id pub-id-type="doi">10.1089/neu.2006.23.345</pub-id>
        </citation>
        <citation citation-type="display-unstructured">McDonald JW, Belegu V (2006) Demyelination and remyelination after spinal cord injury. J Neurotrauma 23:345&#x2013;359 <pub-id pub-id-type="pmid">16629621</pub-id></citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carlson</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Parrish</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Springer</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Doty</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Dossett</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Acute inflammatory response in spinal cord following impact injury</article-title>
          <source>Exp Neurol</source>
          <year>1998</year>
          <volume>151</volume>
          <fpage>77</fpage>
          <lpage>88</lpage>
          <pub-id pub-id-type="doi">10.1006/exnr.1998.6785</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Carlson SL, Parrish ME, Springer JE, Doty K, Dossett L (1998) Acute inflammatory response in spinal cord following impact injury. Exp Neurol 151:77&#x2013;88 <pub-id pub-id-type="pmid">9582256</pub-id></citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dusart</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Schwab</surname>
              <given-names>ME</given-names>
            </name>
          </person-group>
          <article-title>A monoclonal antibody (IN-1) which neutralizes neurite growth inhibitory proteins in the rat CNS recognizes antigens localized in CNS myelin</article-title>
          <source>J Neurocytol</source>
          <year>1994</year>
          <volume>23</volume>
          <fpage>209</fpage>
          <lpage>217</lpage>
          <pub-id pub-id-type="doi">10.1007/BF01275525</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Dusart I, Schwab ME (1994) A monoclonal antibody (IN-1) which neutralizes neurite growth inhibitory proteins in the rat CNS recognizes antigens localized in CNS myelin. J Neurocytol 23:209&#x2013;217 <pub-id pub-id-type="pmid">7518504</pub-id></citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fleming</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Norenberg</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Ramsay</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Dekaban</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Marcillo</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Saenz</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Pasquale-Styles</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dietrich</surname>
              <given-names>WD</given-names>
            </name>
            <name>
              <surname>Weaver</surname>
              <given-names>LC</given-names>
            </name>
          </person-group>
          <article-title>The cellular inflammatory response in human spinal cords after injury</article-title>
          <source>Brain</source>
          <year>2006</year>
          <volume>129</volume>
          <fpage>3249</fpage>
          <lpage>3269</lpage>
          <pub-id pub-id-type="doi">10.1093/brain/awl296</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Fleming CJ, Norenberg MD, Ramsay DA, Dekaban GA, Marcillo AE, Saenz AD, Pasquale-Styles M, Dietrich WD, Weaver LC (2006) The cellular inflammatory response in human spinal cords after injury. Brain 129:3249&#x2013;3269 <pub-id pub-id-type="pmid">17071951</pub-id></citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hagg</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Oudega</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Degenerative and spontaneous regenerative processes after spinal cord injury</article-title>
          <source>J Neurotrauma</source>
          <year>2006</year>
          <volume>23</volume>
          <fpage>264</fpage>
          <lpage>280</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hagg T, Oudega M (2006) Degenerative and spontaneous regenerative processes after spinal cord injury. J Neurotrauma 23:264&#x2013;280 <pub-id pub-id-type="pmid">16629615</pub-id></citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Blakemore</surname>
              <given-names>WF</given-names>
            </name>
            <name>
              <surname>Franklin</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>Remyelinating the demyelinated CNS</article-title>
          <source>Novartis Found Symp</source>
          <year>2000</year>
          <volume>231</volume>
          <fpage>289</fpage>
          <lpage>298</lpage>
        </citation>
        <citation citation-type="display-unstructured">Blakemore WF, Franklin RJ (2000) Remyelinating the demyelinated CNS. Novartis Found Symp 231:289&#x2013;298 <pub-id pub-id-type="pmid">11131544</pub-id></citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gilson</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Blakemore</surname>
              <given-names>WF</given-names>
            </name>
          </person-group>
          <article-title>Failure of remyelination in areas of demyelination produced in the spinal cord of old rats</article-title>
          <source>Neuropathol Appl Neurobiol</source>
          <year>1993</year>
          <volume>19</volume>
          <fpage>173</fpage>
          <lpage>181</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gilson J, Blakemore WF (1993) Failure of remyelination in areas of demyelination produced in the spinal cord of old rats. Neuropathol Appl Neurobiol 19:173&#x2013;181 <pub-id pub-id-type="pmid">8316337</pub-id></citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ludwin</surname>
              <given-names>SK</given-names>
            </name>
          </person-group>
          <article-title>Remyelination in the central nervous system and the peripheral nervous system</article-title>
          <source>Adv Neurol</source>
          <year>1988</year>
          <volume>47</volume>
          <fpage>215</fpage>
          <lpage>254</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ludwin SK (1988) Remyelination in the central nervous system and the peripheral nervous system. Adv Neurol 47:215&#x2013;254 <pub-id pub-id-type="pmid">3278518</pub-id></citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smith</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Blakemore</surname>
              <given-names>WF</given-names>
            </name>
            <name>
              <surname>McDonald</surname>
              <given-names>WI</given-names>
            </name>
          </person-group>
          <article-title>Central remyelination restores secure conduction</article-title>
          <source>Nature</source>
          <year>1979</year>
          <volume>280</volume>
          <fpage>395</fpage>
          <lpage>396</lpage>
          <pub-id pub-id-type="doi">10.1038/280395a0</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Smith EJ, Blakemore WF, McDonald WI (1979) Central remyelination restores secure conduction. Nature 280:395&#x2013;396 <pub-id pub-id-type="pmid">460414</pub-id></citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Norton</surname>
              <given-names>WT</given-names>
            </name>
          </person-group>
          <article-title>Do oligodendrocytes divide?</article-title>
          <source>Neurochem Res</source>
          <year>1996</year>
          <volume>21</volume>
          <fpage>495</fpage>
          <lpage>503</lpage>
          <pub-id pub-id-type="doi">10.1007/BF02527715</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Norton WT (1996) Do oligodendrocytes divide? Neurochem Res 21:495&#x2013;503 <pub-id pub-id-type="pmid">8734444</pub-id></citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gensert</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Goldman</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
          <article-title>Endogenous progenitors remyelinate demyelinated axons in the adult CNS</article-title>
          <source>Neuron</source>
          <year>1997</year>
          <volume>19</volume>
          <fpage>197</fpage>
          <lpage>203</lpage>
          <pub-id pub-id-type="doi">10.1016/S0896-6273(00)80359-1</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Gensert JM, Goldman JE (1997) Endogenous progenitors remyelinate demyelinated axons in the adult CNS. Neuron 19:197&#x2013;203 <pub-id pub-id-type="pmid">9247275</pub-id></citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Horner</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Power</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Kempermann</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Kuhn</surname>
              <given-names>HG</given-names>
            </name>
            <name>
              <surname>Palmer</surname>
              <given-names>TD</given-names>
            </name>
            <name>
              <surname>Winkler</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Thal</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Gage</surname>
              <given-names>FH</given-names>
            </name>
          </person-group>
          <article-title>Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord</article-title>
          <source>J Neurosci</source>
          <year>2000</year>
          <volume>20</volume>
          <fpage>2218</fpage>
          <lpage>2228</lpage>
        </citation>
        <citation citation-type="display-unstructured">Horner PJ, Power AE, Kempermann G, Kuhn HG, Palmer TD, Winkler J, Thal LJ, Gage FH (2000) Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord. J Neurosci 20:2218&#x2013;2228 <pub-id pub-id-type="pmid">10704497</pub-id></citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McTigue</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Wei</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Stokes</surname>
              <given-names>BT</given-names>
            </name>
          </person-group>
          <article-title>Proliferation of NG2-positive cells and altered oligodendrocyte numbers in the contused rat spinal cord</article-title>
          <source>J Neurosci</source>
          <year>2001</year>
          <volume>21</volume>
          <fpage>3392</fpage>
          <lpage>3400</lpage>
        </citation>
        <citation citation-type="display-unstructured">McTigue DM, Wei P, Stokes BT (2001) Proliferation of NG2-positive cells and altered oligodendrocyte numbers in the contused rat spinal cord. J Neurosci 21:3392&#x2013;3400 <pub-id pub-id-type="pmid">11331369</pub-id></citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barres</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Raff</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Gaese</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Bartke</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Dechant</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Barde</surname>
              <given-names>YA</given-names>
            </name>
          </person-group>
          <article-title>A crucial role for neurotrophin-3 in oligodendrocyte development</article-title>
          <source>Nature</source>
          <year>1994</year>
          <volume>367</volume>
          <fpage>371</fpage>
          <lpage>375</lpage>
          <pub-id pub-id-type="doi">10.1038/367371a0</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Barres BA, Raff MC, Gaese F, Bartke I, Dechant G, Barde YA (1994) A crucial role for neurotrophin-3 in oligodendrocyte development. Nature 367:371&#x2013;375 <pub-id pub-id-type="pmid">8114937</pub-id></citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rosano</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Felipe-Cuervo</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>PM</given-names>
            </name>
          </person-group>
          <article-title>Regenerative potential of adult O1+ oligodendrocytes</article-title>
          <source>Glia</source>
          <year>1999</year>
          <volume>27</volume>
          <fpage>189</fpage>
          <lpage>202</lpage>
          <pub-id pub-id-type="doi">10.1002/(SICI)1098-1136(199909)27:3&lt;189::AID-GLIA1&gt;3.0.CO;2-I</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Rosano C, Felipe-Cuervo E, Wood PM (1999) Regenerative potential of adult O1+ oligodendrocytes. Glia 27:189&#x2013;202 <pub-id pub-id-type="pmid">10457366</pub-id></citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stankoff</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Aigrot</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Noel</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Wattilliaux</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Zalc</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Lubetzki</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Ciliary neuro-trophic factor (CNTF) enhances myelin formation: a novel role for CNTF and CNTF-related molecules</article-title>
          <source>J Neurosci</source>
          <year>2002</year>
          <volume>22</volume>
          <fpage>9221</fpage>
          <lpage>9227</lpage>
        </citation>
        <citation citation-type="display-unstructured">Stankoff B, Aigrot MS, Noel F, Wattilliaux A, Zalc B, Lubetzki C (2002) Ciliary neuro-trophic factor (CNTF) enhances myelin formation: a novel role for CNTF and CNTF-related molecules. J Neurosci 22:9221&#x2013;9227 <pub-id pub-id-type="pmid">12417647</pub-id></citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McTigue</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Horner</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Stokes</surname>
              <given-names>BT</given-names>
            </name>
            <name>
              <surname>Gage</surname>
              <given-names>FH</given-names>
            </name>
          </person-group>
          <article-title>Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord</article-title>
          <source>J Neurosci</source>
          <year>1998</year>
          <volume>18</volume>
          <fpage>5354</fpage>
          <lpage>5365</lpage>
        </citation>
        <citation citation-type="display-unstructured">McTigue DM, Horner PJ, Stokes BT, Gage FH (1998) Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord. J Neurosci 18:5354&#x2013;5365 <pub-id pub-id-type="pmid">9651218</pub-id></citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baumann</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Pham-Dinh</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Biology of oligodendrocyte and myelin in the mammalian central nervous system</article-title>
          <source>Physiol Rev</source>
          <year>2001</year>
          <volume>81</volume>
          <fpage>871</fpage>
          <lpage>927</lpage>
        </citation>
        <citation citation-type="display-unstructured">Baumann N, Pham-Dinh D (2001) Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 81:871&#x2013;927 <pub-id pub-id-type="pmid">11274346</pub-id></citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>David</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lacroix</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Molecular approaches to spinal cord repair</article-title>
          <source>Annu Rev Neurosci</source>
          <year>2003</year>
          <volume>26</volume>
          <fpage>411</fpage>
          <lpage>440</lpage>
          <pub-id pub-id-type="doi">10.1146/annurev.neuro.26.043002.094946</pub-id>
        </citation>
        <citation citation-type="display-unstructured">David S, Lacroix S (2003) Molecular approaches to spinal cord repair. Annu Rev Neurosci 26:411&#x2013;440 <pub-id pub-id-type="pmid">12626698</pub-id></citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Horner</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Gage</surname>
              <given-names>FH</given-names>
            </name>
          </person-group>
          <article-title>Regenerating the damaged central nervous system</article-title>
          <source>Nature</source>
          <year>2000</year>
          <volume>407</volume>
          <fpage>963</fpage>
          <lpage>970</lpage>
          <pub-id pub-id-type="doi">10.1038/35039559</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Horner PJ, Gage FH (2000) Regenerating the damaged central nervous system. Nature 407:963&#x2013;970 <pub-id pub-id-type="pmid">11069169</pub-id></citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yan</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>PM</given-names>
            </name>
          </person-group>
          <article-title>NT-3 weakly stimulates proliferation of adult rat O1(&#x2212;)O4(+) oligodendrocyte-lineage cells and increases oligodendrocyte myelination in vitro</article-title>
          <source>J Neurosci Res</source>
          <year>2000</year>
          <volume>62</volume>
          <fpage>329</fpage>
          <lpage>335</lpage>
          <pub-id pub-id-type="doi">10.1002/1097-4547(20001101)62:3&lt;329::AID-JNR2&gt;3.0.CO;2-C</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Yan H, Wood PM (2000) NT-3 weakly stimulates proliferation of adult rat O1(&#x2212;)O4(+) oligodendrocyte-lineage cells and increases oligodendrocyte myelination in vitro. J Neurosci Res 62:329&#x2013;335 <pub-id pub-id-type="pmid">11054801</pub-id></citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goddard</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Berry</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kirvell</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Butt</surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
          <article-title>Fibroblast growth factor-2 inhibits myelin production by oligodendrocytes in vivo</article-title>
          <source>Mol Cell Neurosci</source>
          <year>2001</year>
          <volume>18</volume>
          <fpage>557</fpage>
          <lpage>569</lpage>
          <pub-id pub-id-type="doi">10.1006/mcne.2001.1025</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Goddard DR, Berry M, Kirvell SL, Butt AM (2001) Fibroblast growth factor-2 inhibits myelin production by oligodendrocytes in vivo. Mol Cell Neurosci 18:557&#x2013;569 <pub-id pub-id-type="pmid">11922145</pub-id></citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rathbone</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Middlemiss</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Gysbers</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Andrew</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Herman</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Reed</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Ciccarelli</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Iorio</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Caciagli</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Trophic effects of purines in neurons and glial cells</article-title>
          <source>Prog Neurobiol</source>
          <year>1999</year>
          <volume>59</volume>
          <fpage>663</fpage>
          <lpage>690</lpage>
          <pub-id pub-id-type="doi">10.1016/S0301-0082(99)00017-9</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Rathbone MP, Middlemiss PJ, Gysbers JW, Andrew C, Herman MA, Reed JK, Ciccarelli R, Di Iorio P, Caciagli F (1999) Trophic effects of purines in neurons and glial cells. Prog Neurobiol 59:663&#x2013;690 <pub-id pub-id-type="pmid">10845757</pub-id></citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gysbers</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Guarnieri</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mariggio</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Pietrangelo</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Fano</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Rathbone</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>Extracellular guanosine 5&#x2032; triphosphate enhances nerve growth factor-induced neurite outgrowth via increases in intracellular calcium</article-title>
          <source>Neuroscience</source>
          <year>2000</year>
          <volume>96</volume>
          <fpage>817</fpage>
          <lpage>824</lpage>
          <pub-id pub-id-type="doi">10.1016/S0306-4522(99)00588-6</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Gysbers JW, Guarnieri S, Mariggio MA, Pietrangelo T, Fano G, Rathbone MP (2000) Extracellular guanosine 5&#x2032; triphosphate enhances nerve growth factor-induced neurite outgrowth via increases in intracellular calcium. Neuroscience 96:817&#x2013;824 <pub-id pub-id-type="pmid">10727799</pub-id></citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Iorio</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Caciagli</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Giuliani</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ballerini</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ciccarelli</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sperling</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Zoref-Shani</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Benowitz</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Traversa</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Bombi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Fiorio</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>D&#x2019;Alimonte</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Andrew</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Crocker</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Werstiuk</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Middlemiss</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Rathbone</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>Purine nucleosides protect injured neurons and stimulate neuronal regeneration by intracellular and membrane receptor-mediated mechanisms</article-title>
          <source>Drug Dev Res</source>
          <year>2001</year>
          <volume>52</volume>
          <fpage>303</fpage>
          <lpage>315</lpage>
          <pub-id pub-id-type="doi">10.1002/ddr.1128</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Di Iorio P, Caciagli F, Giuliani P, Ballerini P, Ciccarelli R, Sperling O, Zoref-Shani E, Benowitz L, Traversa U, Bombi G, Fiorio T, D&#x2019;Alimonte I, Andrew CM, Crocker CE, Werstiuk ES, Middlemiss PJ, Rathbone MP (2001) Purine nucleosides protect injured neurons and stimulate neuronal regeneration by intracellular and membrane receptor-mediated mechanisms. Drug Dev Res 52:303&#x2013;315 </citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ciccarelli</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Iorio</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>D&#x2019;Alimonte</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Giulani</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Florio</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Caciagli</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Middlemiss</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Rathbone</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>Cultured astrocyte proliferation induced by extracellular guanosine involves endogenous adenosine and is raised by the co-presence of microglia</article-title>
          <source>Glia</source>
          <year>2000</year>
          <volume>29</volume>
          <fpage>202</fpage>
          <lpage>211</lpage>
          <pub-id pub-id-type="doi">10.1002/(SICI)1098-1136(20000201)29:3&lt;202::AID-GLIA2&gt;3.0.CO;2-C</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Ciccarelli R, Di Iorio P, D&#x2019;Alimonte I, Giulani P, Florio T, Caciagli F, Middlemiss PJ, Rathbone MP (2000) Cultured astrocyte proliferation induced by extracellular guanosine involves endogenous adenosine and is raised by the co-presence of microglia. Glia 29:202&#x2013;211 <pub-id pub-id-type="pmid">10642747</pub-id></citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gysbers</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Rathbone</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>Guanosine enhances NGF-stimulated neurite outgrowth in PC12 cells</article-title>
          <source>Neuroreport</source>
          <year>1992</year>
          <volume>3</volume>
          <fpage>997</fpage>
          <lpage>1000</lpage>
          <pub-id pub-id-type="doi">10.1097/00001756-199211000-00013</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Gysbers JW, Rathbone MP (1992) Guanosine enhances NGF-stimulated neurite outgrowth in PC12 cells. Neuroreport 3:997&#x2013;1000 <pub-id pub-id-type="pmid">1482771</pub-id></citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gysbers</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Rathbone</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>GTP and guanosine synergistically enhance NGF-induced neurite outgrowth from PC12 cells</article-title>
          <source>Int J Dev Neurosci</source>
          <year>1996</year>
          <volume>14</volume>
          <fpage>19</fpage>
          <lpage>34</lpage>
          <pub-id pub-id-type="doi">10.1016/0736-5748(95)00083-6</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Gysbers JW, Rathbone MP (1996) GTP and guanosine synergistically enhance NGF-induced neurite outgrowth from PC12 cells. Int J Dev Neurosci 14:19&#x2013;34 <pub-id pub-id-type="pmid">8779305</pub-id></citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jiang</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Khan</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Buttigieg</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Werstiuk</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Ciccarelli</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Caciagli</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Rathbone</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>Guanosine promotes myelination and functional recovery in chronic spinal injury</article-title>
          <source>Neuroreport</source>
          <year>2003</year>
          <volume>14</volume>
          <fpage>2463</fpage>
          <lpage>2467</lpage>
          <pub-id pub-id-type="doi">10.1097/00001756-200312190-00034</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Jiang S, Khan MI, Lu Y, Wang J, Buttigieg J, Werstiuk ES, Ciccarelli R, Caciagli F, Rathbone MP (2003a) Guanosine promotes myelination and functional recovery in chronic spinal injury. Neuroreport 14:2463&#x2013;2467 <pub-id pub-id-type="pmid">14663211</pub-id></citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Blight</surname>
              <given-names>AR</given-names>
            </name>
          </person-group>
          <article-title>Morphometric analysis of a model of spinal cord injury in guinea pigs, with behavioral evidence of delayed secondary pathology</article-title>
          <source>J Neurol Sci</source>
          <year>1991</year>
          <volume>103</volume>
          <fpage>156</fpage>
          <lpage>171</lpage>
          <pub-id pub-id-type="doi">10.1016/0022-510X(91)90159-5</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Blight AR (1991) Morphometric analysis of a model of spinal cord injury in guinea pigs, with behavioral evidence of delayed secondary pathology. J Neurol Sci 103:156&#x2013;171 <pub-id pub-id-type="pmid">1880533</pub-id></citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gruner</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Yee</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Blight</surname>
              <given-names>AR</given-names>
            </name>
          </person-group>
          <article-title>Histological and functional evaluation of experimental spinal cord injury: evidence of a stepwise response to graded compression</article-title>
          <source>Brain Res</source>
          <year>1996</year>
          <volume>729</volume>
          <fpage>90</fpage>
          <lpage>101</lpage>
          <pub-id pub-id-type="doi">10.1016/0006-8993(96)00366-6</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Gruner JA, Yee AK, Blight AR (1996) Histological and functional evaluation of experimental spinal cord injury: evidence of a stepwise response to graded compression. Brain Res 729:90&#x2013;101 <pub-id pub-id-type="pmid">8874880</pub-id></citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jiang</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Khan</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Middlemiss</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Salgado-Ceballos</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Werstiuk</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Wickson</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Rathbone</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>Enteric glia promote regeneration of transected dorsal root axons into spinal cord of adult rats</article-title>
          <source>Exp Neurol</source>
          <year>2003</year>
          <volume>181</volume>
          <fpage>79</fpage>
          <lpage>83</lpage>
          <pub-id pub-id-type="doi">10.1016/S0014-4886(02)00030-4</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Jiang S, Wang J, Khan MI, Middlemiss PJ, Salgado-Ceballos H, Werstiuk ES, Wickson R, Rathbone MP (2003b) Enteric glia promote regeneration of transected dorsal root axons into spinal cord of adult rats. Exp Neurol 181:79&#x2013;83 <pub-id pub-id-type="pmid">12710936</pub-id></citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jiang</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Khan</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Middlemiss</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Werstiuk</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Crocker</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Ciccarelli</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Caciagli</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Rathbone</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>AIT-082 and methylprednisolone singly, but not in combination, enhance functional and histological improvement after acute spinal cord injury in rats</article-title>
          <source>Int J Immunopathol Pharmacol</source>
          <year>2004</year>
          <volume>17</volume>
          <fpage>353</fpage>
          <lpage>366</lpage>
        </citation>
        <citation citation-type="display-unstructured">Jiang S, Khan MI, Middlemiss PJ, Lu Y, Werstiuk ES, Crocker CE, Ciccarelli R, Caciagli F, Rathbone MP (2004) AIT-082 and methylprednisolone singly, but not in combination, enhance functional and histological improvement after acute spinal cord injury in rats. Int J Immunopathol Pharmacol 17:353&#x2013;366 <pub-id pub-id-type="pmid">15461869</pub-id></citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Basso</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Beattie</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Bresnahan</surname>
              <given-names>JC</given-names>
            </name>
          </person-group>
          <article-title>A sensitive and reliable locomotor rating scale for open field testing in rats</article-title>
          <source>J Neurotrauma</source>
          <year>1995</year>
          <volume>12</volume>
          <fpage>1</fpage>
          <lpage>21</lpage>
        </citation>
        <citation citation-type="display-unstructured">Basso DM, Beattie MS, Bresnahan JC (1995) A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 12:1&#x2013;21 <pub-id pub-id-type="pmid">7783230</pub-id></citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Basso</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Beattie</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Bresnahan</surname>
              <given-names>JC</given-names>
            </name>
          </person-group>
          <article-title>Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection</article-title>
          <source>Exp Neurol</source>
          <year>1996</year>
          <volume>139</volume>
          <fpage>244</fpage>
          <lpage>256</lpage>
          <pub-id pub-id-type="doi">10.1006/exnr.1996.0098</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Basso DM, Beattie MS, Bresnahan JC (1996) Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol 139:244&#x2013;256 <pub-id pub-id-type="pmid">8654527</pub-id></citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bruck</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Kuhlmann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Stadelmann</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Remyelination in multiple sclerosis</article-title>
          <source>J Neurol Sci</source>
          <year>2003</year>
          <volume>206</volume>
          <fpage>181</fpage>
          <lpage>185</lpage>
          <pub-id pub-id-type="doi">10.1016/S0022-510X(02)00191-0</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Bruck W, Kuhlmann T, Stadelmann C (2003) Remyelination in multiple sclerosis. J Neurol Sci 206:181&#x2013;185 <pub-id pub-id-type="pmid">12559508</pub-id></citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Friedman</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Hockfield</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Black</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Woodruff</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Waxman</surname>
              <given-names>SG</given-names>
            </name>
          </person-group>
          <article-title>In situ demonstration of mature oligodendrocytes and their processes: an immunocytochemical study with a new monoclonal antibody, rip</article-title>
          <source>Glia</source>
          <year>1989</year>
          <volume>2</volume>
          <fpage>380</fpage>
          <lpage>390</lpage>
          <pub-id pub-id-type="doi">10.1002/glia.440020510</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Friedman B, Hockfield S, Black JA, Woodruff KA, Waxman SG (1989) In situ demonstration of mature oligodendrocytes and their processes: an immunocytochemical study with a new monoclonal antibody, rip. Glia 2:380&#x2013;390 <pub-id pub-id-type="pmid">2530173</pub-id></citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ciccarelli</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Iorio</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Giuliani</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>D&#x2019;Alimonte</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Ballerini</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Caciagli</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Rathbone</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>Rat cultured astrocytes release guanine-based purines in basal conditions and after hypoxia/hypoglycemia</article-title>
          <source>Glia</source>
          <year>1999</year>
          <volume>25</volume>
          <fpage>93</fpage>
          <lpage>98</lpage>
          <pub-id pub-id-type="doi">10.1002/(SICI)1098-1136(19990101)25:1&lt;93::AID-GLIA9&gt;3.0.CO;2-N</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Ciccarelli R, Di Iorio P, Giuliani P, D&#x2019;Alimonte I, Ballerini P, Caciagli F, Rathbone MP (1999) Rat cultured astrocytes release guanine-based purines in basal conditions and after hypoxia/hypoglycemia. Glia 25:93&#x2013;98 <pub-id pub-id-type="pmid">9888301</pub-id></citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Keirstead</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Blakemore</surname>
              <given-names>WF</given-names>
            </name>
          </person-group>
          <article-title>Identification of post-mitotic oligodendrocytes incapable of remyelination within the demyelinated adult spinal cord</article-title>
          <source>J Neuropathol Exp Neurol</source>
          <year>1997</year>
          <volume>56</volume>
          <fpage>1191</fpage>
          <lpage>1201</lpage>
        </citation>
        <citation citation-type="display-unstructured">Keirstead HS, Blakemore WF (1997) Identification of post-mitotic oligodendrocytes incapable of remyelination within the demyelinated adult spinal cord. J Neuropathol Exp Neurol 56:1191&#x2013;1201 <pub-id pub-id-type="pmid">9370229</pub-id></citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Redwine</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Armstrong</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
          <article-title>In vivo proliferation of oligodendrocyte progenitors expressing PDGFalphaR during early remyelination</article-title>
          <source>J Neurobiol</source>
          <year>1998</year>
          <volume>37</volume>
          <fpage>413</fpage>
          <lpage>428</lpage>
          <pub-id pub-id-type="doi">10.1002/(SICI)1097-4695(19981115)37:3&lt;413::AID-NEU7&gt;3.0.CO;2-8</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Redwine JM, Armstrong RC (1998) In vivo proliferation of oligodendrocyte progenitors expressing PDGFalphaR during early remyelination. J Neurobiol 37:413&#x2013;428 <pub-id pub-id-type="pmid">9828047</pub-id></citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Polito</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Reynolds</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>NG2-expressing cells as oligodendrocyte progenitors in the normal and demyelinated adult central nervous system</article-title>
          <source>J Anat</source>
          <year>2005</year>
          <volume>207</volume>
          <fpage>707</fpage>
          <lpage>716</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1469-7580.2005.00454.x</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Polito A, Reynolds R (2005) NG2-expressing cells as oligodendrocyte progenitors in the normal and demyelinated adult central nervous system. J Anat 207:707&#x2013;716 <pub-id pub-id-type="pmid">16367798</pub-id></citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dawson</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Polito</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Levine</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Reynolds</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>NG2-expressing glial progenitor cells: an abundant and widespread population of cycling cells in the adult rat CNS</article-title>
          <source>Mol Cell Neurosci</source>
          <year>2003</year>
          <volume>24</volume>
          <fpage>476</fpage>
          <lpage>488</lpage>
          <pub-id pub-id-type="doi">10.1016/S1044-7431(03)00210-0</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Dawson MR, Polito A, Levine JM, Reynolds R (2003) NG2-expressing glial progenitor cells: an abundant and widespread population of cycling cells in the adult rat CNS. Mol Cell Neurosci 24:476&#x2013;488 <pub-id pub-id-type="pmid">14572468</pub-id></citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carroll</surname>
              <given-names>WM</given-names>
            </name>
            <name>
              <surname>Jennings</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Ironside</surname>
              <given-names>LJ</given-names>
            </name>
          </person-group>
          <article-title>Identification of the adult resting progenitor cell by autoradiographic tracking of oligodendrocyte precursors in experimental CNS demyelination</article-title>
          <source>Brain</source>
          <year>1998</year>
          <volume>121</volume>
          <fpage>293</fpage>
          <lpage>302</lpage>
          <pub-id pub-id-type="doi">10.1093/brain/121.2.293</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Carroll WM, Jennings AR, Ironside LJ (1998) Identification of the adult resting progenitor cell by autoradiographic tracking of oligodendrocyte precursors in experimental CNS demyelination. Brain 121:293&#x2013;302 <pub-id pub-id-type="pmid">9549507</pub-id></citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Keirstead</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Levine</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Blakemore</surname>
              <given-names>WF</given-names>
            </name>
          </person-group>
          <article-title>Response of the oligodendrocyte progenitor cell population (defined by NG2 labelling) to demyelination of the adult spinal cord</article-title>
          <source>Glia</source>
          <year>1998</year>
          <volume>22</volume>
          <fpage>161</fpage>
          <lpage>170</lpage>
          <pub-id pub-id-type="doi">10.1002/(SICI)1098-1136(199802)22:2&lt;161::AID-GLIA7&gt;3.0.CO;2-A</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Keirstead HS, Levine JM, Blakemore WF (1998) Response of the oligodendrocyte progenitor cell population (defined by NG2 labelling) to demyelination of the adult spinal cord. Glia 22:161&#x2013;170 <pub-id pub-id-type="pmid">9537836</pub-id></citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Levine</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Reynolds</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Activation and proliferation of endogenous oligodendrocyte precursor cells during ethidium bromide-induced demyelination</article-title>
          <source>Exp Neurol</source>
          <year>1999</year>
          <volume>160</volume>
          <fpage>333</fpage>
          <lpage>347</lpage>
          <pub-id pub-id-type="doi">10.1006/exnr.1999.7224</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Levine JM, Reynolds R (1999) Activation and proliferation of endogenous oligodendrocyte precursor cells during ethidium bromide-induced demyelination. Exp Neurol 160:333&#x2013;347 <pub-id pub-id-type="pmid">10619551</pub-id></citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lytle</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Wrathall</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Glial cell loss, proliferation and replacement in the contused murine spinal cord</article-title>
          <source>Eur J Neurosci</source>
          <year>2007</year>
          <volume>25</volume>
          <fpage>1711</fpage>
          <lpage>1724</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1460-9568.2007.05390.x</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Lytle JM, Wrathall JR (2007) Glial cell loss, proliferation and replacement in the contused murine spinal cord. Eur J Neurosci 25:1711&#x2013;1724 <pub-id pub-id-type="pmid">17432960</pub-id></citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Williams</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Piaton</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Lubetzki</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Astrocytes&#x2014;friends or foes in multiple sclerosis?</article-title>
          <source>Glia</source>
          <year>2007</year>
          <volume>55</volume>
          <fpage>1300</fpage>
          <lpage>1312</lpage>
          <pub-id pub-id-type="doi">10.1002/glia.20546</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Williams A, Piaton G, Lubetzki C (2007) Astrocytes&#x2014;friends or foes in multiple sclerosis? Glia 55:1300&#x2013;1312 <pub-id pub-id-type="pmid">17626262</pub-id></citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Iorio</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Kleywegt</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ciccarelli</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Traversa</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Andrew</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Crocker</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Werstiuk</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Rathbone</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>Mechanisms of apoptosis induced by purine nucleosides in astrocytes</article-title>
          <source>Glia</source>
          <year>2002</year>
          <volume>38</volume>
          <fpage>179</fpage>
          <lpage>190</lpage>
          <pub-id pub-id-type="doi">10.1002/glia.10055</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Di Iorio P, Kleywegt S, Ciccarelli R, Traversa U, Andrew CM, Crocker CE, Werstiuk ES, Rathbone MP (2002) Mechanisms of apoptosis induced by purine nucleosides in astrocytes. Glia 38:179&#x2013;190 <pub-id pub-id-type="pmid">11968056</pub-id></citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Iorio</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ballerini</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Traversa</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Nicoletti</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>D&#x2019;Alimonte</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Kleywegt</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Werstiuk</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Rathbone</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Caciagli</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Cicarelli</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>The antiapoptotic effect of guanosine is mediated via the activation of PI3-kinase/Akt/PKB pathway in cultured rat astrocytes</article-title>
          <source>Glia</source>
          <year>2004</year>
          <volume>46</volume>
          <fpage>356</fpage>
          <lpage>368</lpage>
          <pub-id pub-id-type="doi">10.1002/glia.20002</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Di Iorio P, Ballerini P, Traversa U, Nicoletti F, D&#x2019;Alimonte I, Kleywegt S, Werstiuk ES, Rathbone MP, Caciagli F, Cicarelli R (2004) The antiapoptotic effect of guanosine is mediated via the activation of PI3-kinase/Akt/PKB pathway in cultured rat astrocytes. Glia 46:356&#x2013;368 <pub-id pub-id-type="pmid">15095366</pub-id></citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pettifer</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Kleywegt</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bau</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Ramsbottom</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Vertes</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Ciccarelli</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Caciagli</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Werstiuk</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Rathbone</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>Guanosine protects SH-SY5Y cells against beta-amyloid-induced apoptosis</article-title>
          <source>Neuroreport</source>
          <year>2004</year>
          <volume>15</volume>
          <fpage>833</fpage>
          <lpage>836</lpage>
          <pub-id pub-id-type="doi">10.1097/00001756-200404090-00019</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Pettifer KM, Kleywegt S, Bau CJ, Ramsbottom JD, Vertes E, Ciccarelli R, Caciagli F, Werstiuk ES, Rathbone MP (2004) Guanosine protects SH-SY5Y cells against beta-amyloid-induced apoptosis. Neuroreport 15:833&#x2013;836 <pub-id pub-id-type="pmid">15073525</pub-id></citation>
      </ref>
      <ref id="CR53">
        <label>53.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arvidsson</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Collin</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kirik</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kokaia</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Lindvall</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Neuronal replacement from endogenous precursors in the adult brain after stroke</article-title>
          <source>Nat Med</source>
          <year>2002</year>
          <volume>8</volume>
          <fpage>963</fpage>
          <lpage>970</lpage>
          <pub-id pub-id-type="doi">10.1038/nm747</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Arvidsson A, Collin T, Kirik D, Kokaia Z, Lindvall O (2002) Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med 8:963&#x2013;970 <pub-id pub-id-type="pmid">12161747</pub-id></citation>
      </ref>
      <ref id="CR54">
        <label>54.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Xue</surname>
              <given-names>YY</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>YL</given-names>
            </name>
            <name>
              <surname>Signore</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>FY</given-names>
            </name>
          </person-group>
          <article-title>Bcl-2 enhances neurogenesis and inhibits apoptosis of newborn neurons in adult rat brain following a transient middle cerebral artery occlusion</article-title>
          <source>Neurobiol Dis</source>
          <year>2006</year>
          <volume>24</volume>
          <fpage>345</fpage>
          <lpage>356</lpage>
          <pub-id pub-id-type="doi">10.1016/j.nbd.2006.07.012</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Zhang R, Xue YY, Lu SD, Wang Y, Zhang LM, Huang YL, Signore AP, Chen J, Sun FY (2006) Bcl-2 enhances neurogenesis and inhibits apoptosis of newborn neurons in adult rat brain following a transient middle cerebral artery occlusion. Neurobiol Dis 24:345&#x2013;356 <pub-id pub-id-type="pmid">16996745</pub-id></citation>
      </ref>
      <ref id="CR55">
        <label>55.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mason</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Taniike</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Morell</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Matsushima</surname>
              <given-names>GK</given-names>
            </name>
          </person-group>
          <article-title>Mature oligodendrocyte apoptosis precedes IGF-1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination/remyelination</article-title>
          <source>J Neurosci Res</source>
          <year>2000</year>
          <volume>61</volume>
          <fpage>251</fpage>
          <lpage>262</lpage>
          <pub-id pub-id-type="doi">10.1002/1097-4547(20000801)61:3&lt;251::AID-JNR3&gt;3.0.CO;2-W</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Mason JL, Jones JJ, Taniike M, Morell P, Suzuki K, Matsushima GK (2000) Mature oligodendrocyte apoptosis precedes IGF-1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination/remyelination. J Neurosci Res 61:251&#x2013;262 <pub-id pub-id-type="pmid">10900072</pub-id></citation>
      </ref>
      <ref id="CR56">
        <label>56.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vick</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Neuberger</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Devries</surname>
              <given-names>GH</given-names>
            </name>
          </person-group>
          <article-title>Role of adult oligodendrocytes in remyelination after neural injury</article-title>
          <source>J Neurotrauma</source>
          <year>1992</year>
          <volume>9</volume>
          <fpage>S93</fpage>
          <lpage>S103</lpage>
        </citation>
        <citation citation-type="display-unstructured">Vick RS, Neuberger TJ, Devries GH (1992) Role of adult oligodendrocytes in remyelination after neural injury. J Neurotrauma 9:S93&#x2013;S103 <pub-id pub-id-type="pmid">1588636</pub-id></citation>
      </ref>
      <ref id="CR57">
        <label>57.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cohen</surname>
              <given-names>RI</given-names>
            </name>
            <name>
              <surname>Marmur</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Norton</surname>
              <given-names>WT</given-names>
            </name>
            <name>
              <surname>Mehler</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Kessler</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Nerve growth factor and neurotrophin-3 differentially regulate the proliferation and survival of developing rat brain oligodendrocytes</article-title>
          <source>J Neurosci</source>
          <year>1996</year>
          <volume>16</volume>
          <fpage>6433</fpage>
          <lpage>6442</lpage>
        </citation>
        <citation citation-type="display-unstructured">Cohen RI, Marmur R, Norton WT, Mehler MF, Kessler JA (1996) Nerve growth factor and neurotrophin-3 differentially regulate the proliferation and survival of developing rat brain oligodendrocytes. J Neurosci 16:6433&#x2013;6442 <pub-id pub-id-type="pmid">8815922</pub-id></citation>
      </ref>
      <ref id="CR58">
        <label>58.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fressinaud</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Vallat</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Labourdette</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Basic fibroblast growth factor down-regulates myelin basic protein gene expression and alters myelin compaction of mature oligodendrocytes in vitro</article-title>
          <source>J Neurosci Res</source>
          <year>1995</year>
          <volume>40</volume>
          <fpage>285</fpage>
          <lpage>293</lpage>
          <pub-id pub-id-type="doi">10.1002/jnr.490400302</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Fressinaud C, Vallat JM, Labourdette G (1995) Basic fibroblast growth factor down-regulates myelin basic protein gene expression and alters myelin compaction of mature oligodendrocytes in vitro. J Neurosci Res 40:285&#x2013;293 <pub-id pub-id-type="pmid">7745622</pub-id></citation>
      </ref>
      <ref id="CR59">
        <label>59.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McMorris</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Mozell</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Carson</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Shinar</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Meyer</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Marchetti</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Regulation of oligodendrocyte development and central nervous system myelination by insulin-like growth factors</article-title>
          <source>Ann N Y Acad Sci</source>
          <year>1993</year>
          <volume>692</volume>
          <fpage>321</fpage>
          <lpage>334</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1749-6632.1993.tb26247.x</pub-id>
        </citation>
        <citation citation-type="display-unstructured">McMorris FA, Mozell RL, Carson MJ, Shinar Y, Meyer RD, Marchetti N (1993) Regulation of oligodendrocyte development and central nervous system myelination by insulin-like growth factors. Ann N Y Acad Sci 692:321&#x2013;334 <pub-id pub-id-type="pmid">8215042</pub-id></citation>
      </ref>
      <ref id="CR60">
        <label>60.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McMorris</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>McKinnon</surname>
              <given-names>RD</given-names>
            </name>
          </person-group>
          <article-title>Regulation of oligodendrocyte development and CNS myelination by growth factors: prospects for therapy of demyelinating disease</article-title>
          <source>Brain Pathol</source>
          <year>1996</year>
          <volume>6</volume>
          <fpage>313</fpage>
          <lpage>329</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1750-3639.1996.tb00858.x</pub-id>
        </citation>
        <citation citation-type="display-unstructured">McMorris FA, McKinnon RD (1996) Regulation of oligodendrocyte development and CNS myelination by growth factors: prospects for therapy of demyelinating disease. Brain Pathol 6:313&#x2013;329 <pub-id pub-id-type="pmid">8864287</pub-id></citation>
      </ref>
      <ref id="CR61">
        <label>61.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bansal</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Pfeiffer</surname>
              <given-names>SE</given-names>
            </name>
          </person-group>
          <article-title>FGF-2 converts mature oligodendrocytes to a novel phenotype</article-title>
          <source>J Neurosci Res</source>
          <year>1997</year>
          <volume>50</volume>
          <fpage>215</fpage>
          <lpage>228</lpage>
          <pub-id pub-id-type="doi">10.1002/(SICI)1097-4547(19971015)50:2&lt;215::AID-JNR10&gt;3.0.CO;2-7</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Bansal R, Pfeiffer SE (1997) FGF-2 converts mature oligodendrocytes to a novel phenotype. J Neurosci Res 50:215&#x2013;228 <pub-id pub-id-type="pmid">9373031</pub-id></citation>
      </ref>
      <ref id="CR62">
        <label>62.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arnett</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>Mason</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Marino</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Suzuki</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Matsushima</surname>
              <given-names>GK</given-names>
            </name>
            <name>
              <surname>Ting</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
          <article-title>TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination</article-title>
          <source>Nat Neurosci</source>
          <year>2001</year>
          <volume>4</volume>
          <fpage>1116</fpage>
          <lpage>1122</lpage>
          <pub-id pub-id-type="doi">10.1038/nn738</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Arnett HA, Mason J, Marino M, Suzuki K, Matsushima GK, Ting JP (2001) TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci 4:1116&#x2013;1122 <pub-id pub-id-type="pmid">11600888</pub-id></citation>
      </ref>
      <ref id="CR63">
        <label>63.</label>
        <citation citation-type="other">Rathbone MP, Pilutti L, Caciagli F, Jiang S (in press) Neurotrophic effects of extracellular guanosine (review). Nucleosides Nucleotides Nucleic Acids</citation>
      </ref>
      <ref id="CR64">
        <label>64.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Traversa</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Bombi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Iorio</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ciccarelli</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Werstiuk</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Rathbone</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>Specific [(3)H]-guanosine binding sites in rat brain membranes</article-title>
          <source>Br J Pharmacol</source>
          <year>2002</year>
          <volume>135</volume>
          <fpage>969</fpage>
          <lpage>976</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.bjp.0704542</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Traversa U, Bombi G, Di Iorio P, Ciccarelli R, Werstiuk ES, Rathbone MP (2002) Specific [(3)H]-guanosine binding sites in rat brain membranes. Br J Pharmacol 135:969&#x2013;976 <pub-id pub-id-type="pmid">11861325</pub-id></citation>
      </ref>
      <ref id="CR65">
        <label>65.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wolswijk</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells</article-title>
          <source>J Neurosci</source>
          <year>1998</year>
          <volume>18</volume>
          <fpage>601</fpage>
          <lpage>609</lpage>
        </citation>
        <citation citation-type="display-unstructured">Wolswijk G (1998) Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J Neurosci 18:601&#x2013;609 <pub-id pub-id-type="pmid">9425002</pub-id></citation>
      </ref>
      <ref id="CR66">
        <label>66.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chang</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nishiyama</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Peterson</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Prineas</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Trapp</surname>
              <given-names>BD</given-names>
            </name>
          </person-group>
          <article-title>NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions</article-title>
          <source>J Neurosci</source>
          <year>2000</year>
          <volume>20</volume>
          <fpage>6404</fpage>
          <lpage>6412</lpage>
        </citation>
        <citation citation-type="display-unstructured">Chang A, Nishiyama A, Peterson J, Prineas J, Trapp BD (2000) NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J Neurosci 20:6404&#x2013;6412 <pub-id pub-id-type="pmid">10964946</pub-id></citation>
      </ref>
      <ref id="CR67">
        <label>67.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chang</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis</article-title>
          <source>N Engl J Med</source>
          <year>2002</year>
          <volume>346</volume>
          <fpage>165</fpage>
          <lpage>173</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJMoa010994</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Chang A (2002) Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 346:165&#x2013;173 <pub-id pub-id-type="pmid">11796850</pub-id></citation>
      </ref>
      <ref id="CR68">
        <label>68.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scolding</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Franklin</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Stevens</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Heldin</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Compston</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Newcombe</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis</article-title>
          <source>Brain</source>
          <year>1998</year>
          <volume>121</volume>
          <fpage>2221</fpage>
          <lpage>2228</lpage>
          <pub-id pub-id-type="doi">10.1093/brain/121.12.2221</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Scolding N, Franklin R, Stevens S, Heldin CH, Compston A, Newcombe J (1998) Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis. Brain 121:2221&#x2013;2228 <pub-id pub-id-type="pmid">9874475</pub-id></citation>
      </ref>
      <ref id="CR69">
        <label>69.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wilson</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Scolding</surname>
              <given-names>NJ</given-names>
            </name>
            <name>
              <surname>Raine</surname>
              <given-names>CS</given-names>
            </name>
          </person-group>
          <article-title>Co-expression of PDGF alpha receptor and NG2 by oligodendrocyte precursors in human CNS and multiple sclerosis lesions</article-title>
          <source>J Neuroimmunol</source>
          <year>2006</year>
          <volume>176</volume>
          <fpage>162</fpage>
          <lpage>173</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jneuroim.2006.04.014</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Wilson HC, Scolding NJ, Raine CS (2006) Co-expression of PDGF alpha receptor and NG2 by oligodendrocyte precursors in human CNS and multiple sclerosis lesions. J Neuroimmunol 176:162&#x2013;173 <pub-id pub-id-type="pmid">16753227</pub-id></citation>
      </ref>
      <ref id="CR70">
        <label>70.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nait-Oumesmar</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Picard-Riera</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kerninon</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Decker</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Seilhean</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Hoglinger</surname>
              <given-names>GU</given-names>
            </name>
            <name>
              <surname>Hirsch</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>Reynolds</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Baron-Van Evercooren</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Activation of the subventricular zone in multiple sclerosis: evidence for early glial progenitors</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2007</year>
          <volume>104</volume>
          <fpage>4694</fpage>
          <lpage>4699</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0606835104</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Nait-Oumesmar B, Picard-Riera N, Kerninon C, Decker L, Seilhean D, Hoglinger GU, Hirsch EC, Reynolds R, Baron-Van Evercooren A (2007) Activation of the subventricular zone in multiple sclerosis: evidence for early glial progenitors. Proc Natl Acad Sci U S A 104:4694&#x2013;4699 <pub-id pub-id-type="pmid">17360586</pub-id></citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>